BiotechFinances
Back to publications

The weekly letter PDFs are written in French only. You can find the associated articles from the table of contents above, available in your language.

The reader

N° 1143-30-01-2026

April 7, 2026

41.00 € excl. VAT·49.20 € incl. VAT

Table of contents

  • SENSORION LÈVE 60 M€, SANOFI ENTRE AU CAPITAL
  • IA EN DRUG DISCOVERY : POURQUOI LES CONTRATS PLEUVENT SUR IKTOS
  • LES BIG PHARMAS MULTIPLIENT ACQUISITIONS ET ACCORDS POUR FRANCHIR LE PATENT CLIFF
  • MAIS OÙ EST PASSÉE NOTRE BONNE VIEILLE FDA ?
  • LES TÉMOINS : NAWAL OUZREN (SENSORION), GASTON-MATHÉ (IKTOS), VAS NARASIMHAN (NOVARTIS), LUKE MIELS (GSK).
N° 1143-30-01-2026

The letter is available by subscription or individually

Discover subscriptionsLog in

Have a question?

Contact us via WhatsApp

WhatsAppChat on WhatsApp
N° 1143-30-01-2026 | BiotechFinances | BiotechFinances